Diagnosis & Treatment Blogs
-
Our lung tissue is made of different kinds of cells, including neuroendocrine cells. If these cells develop changes in their genome, they can begin to grow out of control and
-
How is Lung Cancer Caught Early?
The point at which lung cancer is diagnosed plays a key role in treatment and survival. The average 5-year survival rate for lung cancer diagnosed while still localized (stage I) -
Finding Clinical Trials for Lung Cancer: Tools and Resources
Participating in a clinical trial gives patients the ability to try the newest treatments that otherwise are not available. There are many ongoing clinical trials testing new lung cancer treatments, including targeted therapies, chemotherapy, radiation therapy, and immunotherapy, alone and in combination. -
An Introduction to Squamous Cell Lung Cancer
Paul K. Paik, MD, medical oncologist and researcher at Memorial Sloan Kettering Cancer Center and a member of LUNGevity’s Scientific Advisory Board, sat down to talk about what squamous cell lung cancer is and where we stand with treatment options for this disease. -
Ask Your Oncologist the Right Questions
Communication is critical to a positive doctor-patient relationship. Knowing the right questions to ask helps ensure you leave your appointments with the information and answers -
World Cancer Day and #CloseTheCareGap in Lung Cancer Screenings
For World Cancer Day this year, the Union for International Cancer Control presents the #CloseTheCareGap initiative. February 4, 2023 will be a day focused on promoting equity in -
Targeted Therapy Options for Patients with EGFR Exon20+ NSCLC
Researchers have made tremendous progress in treating lung cancer by identifying key mutations in genes that drive the growth of lung cancer. Once these “driver” mutations are -
Improving Treatment for KRAS-mutated Lung Cancer
While targeted therapies have emerged in the past decade to improve treatment of non-small cell lung cancer (NSCLC) with some types of driver mutations (such as EGFR and ALK), lung
-
The 2021 Global Lung Cancer Therapy Landscape
On June 1st, 2022, LUNGevity Foundation hosted a Facebook Live to discuss our manuscript titled “The 2021 Global Lung Cancer Therapy Landscape” published in the Journal of Thoracic
-
Palliative Care 101 - Improving Quality of Life While in Treatment
Palliative care, or supportive care, often misunderstood as only end-of-life care, improves patients' quality of life while undergoing treatment. The goal of palliative care is to
-
Discovering a New Approach to Treat Metastatic NSCLC
Lung cancer continues to be the number-one cause of cancer deaths in the United States. In the past decade, we have seen great improvements in the treatment of metastatic lung
-
KRAS: How It Started vs. How It’s Going
On May 28, 2021, the United States Food & Drug Administration (FDA) approved sotorasib as the first targeted therapy for patients with KRAS G12C-positive non-small cell lung cancer (NSCLC).